iShares Biotechnology ETF (IBB) ist ein börsennotiertes Unternehmen im Finanzdienstleistungen Sektor, tätig in der Asset Management Branche. Der Hauptsitz des Unternehmens ist in San Francisco, DE, United States.
IBB hat IPO-Datum 2001-02-12, gelistet an der NASDAQ Global Market, eine Marktkapitalisierung von $8.48B.
The iShares Biotechnology ETF is a non-diversified fund that allocates at least 80% of its assets to biotechnology companies and securities that mirror its underlying index. The fund may invest up to 20% of its assets in derivatives including futures, options, and swap contracts, along with cash and cash equivalents, to achieve its investment objectives. As a passively managed exchange-traded fund, it provides investors with broad exposure to the biotechnology sector through a single, liquid investment vehicle.
